1 study found for:    19255327 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors
Condition: Differentiated Thyroid Cancer
Intervention:

Indicates status has not been verified in more than two years